Tag: FDA guidance

Modified-Release Bioequivalence: Special Considerations for Regulatory Approval

Aug, 8 2026| 0 Comments

Explore the complex regulatory and technical considerations for bioequivalence studies of modified-release formulations, including FDA vs EMA guidelines, pharmacokinetic parameters, and development challenges.